Reduced P50 suppression is associated with the cognitive disorganisation dimension of schizotypy

Schizophrenia Research

Volumn 97, Issue 1-3, 2007, Pages 152-162

  Evans, Lisa H ^a   Gray, Nicola S ^a,b   Snowden, Robert J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Glanrhyd Hospital   (United Kingdom)

Author keywords

Disorganisation; Event related potentials (ERPs); P50; Schizophrenia; Schizotypy; Sensory gating

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; AUDITORY STIMULATION; COGNITIVE DEFECT; DISEASE ASSOCIATION; EVOKED RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MULTIPLE REGRESSION; NEGATIVE SYNDROME; NORMAL HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; STIMULUS RESPONSE; SYMPTOMATOLOGY;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; AROUSAL; ATTENTIONAL BLINK; CEREBRAL CORTEX; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; NEURAL INHIBITION; SCHIZOTYPAL PERSONALITY DISORDER; SIGNAL PROCESSING, COMPUTER-ASSISTED; STUDENTS;

EID: 36048939040     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.07.019     Document Type: Article

References (73)

1. Adler L.E., Pachtman E., Franks R.D., Pecevich M., Waldo M.C., and Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol. Psychiatry 17 (1982) 639-654
2. Adler L.E., Waldo M.C., Tatcher A., Cawthra E., Baker N., and Freedman R. Lack of relationship of auditory gating defects to negative symptoms in schizophrenia. Schizophr. Res. 3 (1990) 131-138
3. Adler L.E., Hoffer L.J., Griffith J., Waldo M.C., and Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol. Psychiatry 32 (1992) 607-616
4. Adler L.E., Hoffer L.D., Wiser A., and Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry 150 (1993) 1856-1861
5. Adler L.E., Cawthre E.M., Donovan K.A., Harris J.G., Nagamoto H.T., Olincy A., et al. Improved P50 auditory gating with ondansetron in medicated schizophrenia patients. Am. J. Psychiatry 162 (2005) 386-388
6. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS) (1984), University of Iowa, Iowa City
7. Arango C., Summerfelt A., and Buchanan R.W. Olanzapine effects on auditory sensory gating in schizophrenia. Am. J. Psychiatry 160 (2003) 2066-2068
8. Becker J., Gomes I., Ghisolfi E.S., Schuch A., Ramos F.L., Ehlers J.A., et al. Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia. Clin. Neurophysiol. 115 (2004) 396-401
9. Boutros N.N., Zouridakis G., and Overall J. Replication and extension of P50 findings in schizophrenia. Clin. Electroencephalogr. 22 (1991) 40-45
10. Boutros N., Zouridakis G., Rustin T., Peabody C., and Warner D. The P50 component of the auditory evoked potential and subtypes of schizophrenia. Psychiatry Res. 47 (1993) 243-254
11. Boutros N.N., Belger A., Campbell D., D'Souza C., and Krystal J. Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report. Psychiatry Res. 88 (1999) 119-130
12. Boutros N.N., Korzyukov O., Jansen B., Feingold A., and Bell M. Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res. 126 (2004) 203-215
13. Braff D.L., and Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry 47 (1990) 181-188
14. Burch G.S., Steel C., and Hemsley D.R. Oxford-Liverpool Inventory of Feelings and Experiences: reliability in an experimental population. Br. J. Clin. Psychol. 37 (1998) 107-108
15. Cadenhead K.S., Light G.A., Geyer M.A., and Braff D.L. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Schizophr. Res. 157 (2000) 55-59
16. Claridge G. Schizotypy: Implications for Illness and Health (1997), Oxford University Press, London
17. Clementz B.A., and Blumenfeld L.D. Multichannel electroencephalographic assessment of auditory evoked response suppression in schizophrenia. Exp. Brain Res. 139 (2001) 377-390
18. Clementz B.A., Geyer M.A., and Braff D.L. P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis. Biol. Psychiatry 41 (1997) 1035-1044
19. Clementz B.A., Geyer M.A., and Braff D.L. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr. Res. 30 (1998) 71-80
20. Clementz B.A., Geyer M.A., and Braff D.L. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am. J. Psychiatry 155 (1998) 1691-1694
21. Coppola R. Isolating low frequency activity EEG spectrum analysis. Electroencephalogr. Clin. Neurophysiol. 46 (1979) 224-226
22. Croft R.J., Lee A., Bertolot J., and Gruzelier J.H. Associations of P50 suppression and desensitization with perceptual and cognitive features of "unreality" in schizotypy. Biol. Psychiatry 50 (2001) 441-446
23. Croft R.J., Dimoska A., Gonsalvez C.J., and Clarke A.R. Suppression of P50 evoked potential component, schizotypal beliefs and smoking. Psychiatry Res. 128 (2004) 53-62
24. Dalack G.W., Healy D.J., and Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am. J. Psychiatry 155 (1998) 1490-1501
25. Eccles J.C. The Inhibitory Pathways of the Central Nervous System (1969), Liverpool University Press, Liverpool, UK
26. Erwin R.J., Turetsky B.I., Moberg P., Gur R.C., and Gur R.E. P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention. Schizophr. Res. 33 (1998) 157-167
27. Evans L.H., Gray N.S., and Snowden R.J. Prepulse inhibition of startle and its moderation by schizotypy and smoking. Psychophysiology 42 (2005) 223-231
28. Evans L.H., Gray N.S., and Snowden R.J. A new continuous within-participants latent inhibition task: examining associations with schizotypy dimensions, smoking status and gender. Biol. Psychol. 74 (2007) 365-373
29. Freedman R., Adler L.E., Waldo M.C., Pachtman E., and Franks R.D. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol. Psychiatry 18 (1983) 537-551
30. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 587-592
31. Gerlach J., and Peacock L. New antipsychotics: the present status. Int. Clin. Psychopharmacol. 10 Suppl. 3 (1995) 39-48
32. Goff D.C., Henderson D.C., and Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am. J. Psychiatry 149 (1992) 1189-1194
33. Graham F.K. Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology 12 (1975) 238-248
34. Gruzelier J., Burgess A., Stygall J., Irving G., and Raine A. Patterns of cognitive asymmetry and syndromes of schizotypal personality. Psychiatry Res. 56 (1995) 71-79
35. Gutterman Y., Josiassen R.C., and Bashore T.R. Attentional influence on the P50 component of the auditory event-related potential. Int. J. Psychophysiol. 12 (1992) 197-209
36. Hetrick W.P., Sandman C.A., Bunney Jr. W.E., Jin Y., Potkin S.G., and White M.H. Gender differences in gating of the auditory evoked potential in normal subjects. Biol. Psychiatry 39 (1996) 51-58
37. Huang M.X., Edgar J.C., Thoma R.J., Hanlon F.M., Moses S.N., Lee R.R., et al. Predicting EEG responses using MEG sources in superior temporal gyrus reveals source asynchrony in patients with schizophrenia. Clin. Neurophysiol. 114 (2003) 835-850
38. Jerger K., Biggins C., and Fein G. P50 suppression is not affected by attentional manipulations. Biol. Psychiatry 31 (1992) 365-377
39. Jin Y., Bunney Jr. W.E., Sandman C.A., Patterson J.V., Fleming K., Moenter J.R., et al. Is P50 suppression a measure of sensory gating in schizophrenia?. Biol. Psychiatry 43 (1998) 873-878
40. Judd L.L., McAdams L., Budnick B., and Braff D.L. Sensory gating deficits in schizophrenia: new results. Am. J. Psychiatry 149 (1992) 488-493
41. Kaiser J., and Gruzelier J.H. Timing of puberty and syndromes of schizotypy: a replication. Int. J. Psychophysiol. 34 (1999) 237-247
42. Karper L.P., Freeman G.K., Grillon C., Morgan III C.A., Charney D.S., and Krystal J.H. Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis. J. Neuropsychiatry Clin. Neurosci. 8 (1996) 60-66
43. Kathmann N., and Engel R.R. Sensory gating in normals and schizophrenics: a failure to find strong P50 suppression in normals. Biol. Psychiatry 27 (1990) 1216-1226
44. King D.J. Psychomotor impairment and cognitive disturbances induced by neuroleptics. Acta Psychiatr. Scand. 89 Suppl. 380 (1994) 53-58
45. Liddle P.F. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br. J. Psychiatry 151 (1987) 145-151
46. Light G.A., and Braff D.L. Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients?. Biol. Psychiatry 47 (2000) 463-467
47. Light G.A., Geyer M.A., Clementez B.A., Cadenhead K.S., and Braff D.L. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am. J. Psychiatry 157 (2000) 767-771
48. Louchart-de la Chapelle S., Levillain D., Menard J.F., Van der Elst A., Allio G., Haouzir S., et al. P50 inhibitory gating deficit is correlated with the negative symptomatology of schizophrenia. Psychiatry Res. 136 (2005) 27-34
49. Mason O., Claridge G., and Jackson M. New scales for the assessment of schizotypy. Pers. Individ. Differ. 18 (1995) 7-13
50. Morrison A.P., French P., Lewis S.W., Roberts M., Raja S., Neil S.T., et al. Psychological factors in people at ultra-high risk of psychosis: comparisons with non-patients and associations with symptoms. Psychol. Med. 36 (2006) 1395-1404
51. Näätänen R. The role of attention in auditory information processing as revealed by event-related potentials and other brain measures of cognitive function. Behav. Brain Sci. 13 (1990) 201-288
52. Nagamoto H.T., Adler L.E., Waldo M.C., and Freedman R. Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biol. Psychiatry 25 (1989) 549-561
53. Nagamoto H.T., Adler L.E., Waldo M.C., Griffith J., and Freedman R. Gating of auditory response in schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave. Schizophr. Res. 4 (1991) 31-40
54. Nagamoto H.T., Adler L.E., Hea R.A., Griffith J.M., McRae K.A., and Freedman R. Gating of auditory P50 in schizophrenics: unique effects of clozapine. Biol. Psychiatry 40 (1996) 181-188
55. Nettle D. Schizotypy and mental health amongst poets, visual artists, and mathematicians. J. Res. Pers. 40 (2006) 876-890
56. O'Driscoll G.A., Lenzenweger M.F., and Holzman P.S. Antisaccades and smooth pursuit eye tracking and schizotypy. Arch. Gen. Psychiatry 55 (1998) 837-843
57. Perry W., and Braff D.L. Information-processing deficits and thought disorder in schizophrenia. Am. J. Psychiatry 151 (1994) 363-367
58. Perry W., Geyer M.A., and Braff D.L. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch. Gen. Psychiatry 56 (1999) 277-281
59. Poreh A.M., Ross T.P., and Whitman R.D. Reexamination of executive functions in psychosis-prone college students. Pers. Individ. Differ. 18 (1995) 535-539
60. Ringel T.M., Heidrich A., Jacob C.P., and Fallgatter A.J. Sensory gating deficit in a subtype of chronic schizophrenic patients. Psychiatry Res. 125 (2004) 237-245
61. Sharma T. Cognitive effects of conventional and atypical antipsychotics in schizophrenia. Br. J. Psychiatry 174 (1999) 44-51
62. Siegel C., Waldo M., Mizner G., Adler L.E., and Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch. Gen. Psychiatry 41 (1984) 607-612
63. Smith D.A., Boutros N.N., and Schwarzopf S.B. Reliability of P50 auditory event-related potential indices of sensory gating. Psychophysiology 31 (1994) 495-502
64. Thoma R.J., Hanlon F.M., Moses S.N., Ricker D., Huang M., Edgar C., et al. M50 sensory gating predicts negative symptoms in schizophrenia. Schizophr. Res. 73 (2005) 311-318
65. Venables P.H. Input dysfunction in schizophrenia. In: Maher B.A. (Ed). Progress in Experimental Personality Research (1964), Academic Press, New York 1-47
66. Vollema M.G., and van den Bosch R.J. The multidimensionality of schizotypy. Schizophr. Bull. 21 (1995) 19-31
67. Waldo M.C., Adler L.E., and Freedman R. Defects in auditory sensory gating and their apparent compensation in relatives of schizophrenics. Schizophr. Res. 1 (1988) 19-24
68. Wan L., Crawford H.J., and Boutros N. P50 sensory gating: impact of high vs. low schizotypal personality and smoking status. Int. J. Psychophysiol. 60 (2006) 1-9
69. Wang J., Miyazato H., Hokama H., Hiramatsu K., and Kondo T. Correlation between P50 suppression and psychometric schizotypy among non-clinical Japanese subjects. Int. J. Psychophysiol. 52 (2004) 147-157
70. Ward P.B., Hoffer L.D., Liebert B.J., Catts S.V., O'Donnell M., and Adler L.E. Replication of a P50 auditory gating deficit in Australian patients with schizophrenia. Psychiatry Res. 64 (1996) 121-135
71. White P.M., and Yee C.M. Effects of attentional and stressor manipulations on the P50 gating response. Psychophysiology 34 (1997) 703-711
72. Yee C.M., Nuechterlein K.H., Morris S.E., and White P.M. P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects. J. Abnorm. Psychology 4 (1998) 691-698
73. Ziedonis D.M., Kosten T.R., Glazer W.M., and Frances R.J. Nicotine dependence and schizophrenia. Hosp. Community Psychiatry 45 (1994) 204-206